Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1995-02-09
1996-06-25
Bernhardt, Emily
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
544392, 544394, 564222, 564428, C07D295033, C07D295096, A61K 31495
Patent
active
055300022
ABSTRACT:
Compounds of formula: ##STR1## in which X represents a hydrogen atom, a C.sub.1 -C.sub.3 alkoxy group or a cyclopropylmethoxy group and Y represents a hydrogen atom or a methoxy group, are useful in the therapy of conditions.
REFERENCES:
patent: 4130646 (1978-12-01), Vogt et al.
patent: 4845221 (1989-07-01), Stack et al.
patent: 5194437 (1993-03-01), Peglion et al.
Renth et al, Chemical Abstracts, vol. 76, No. 113247 (1972).
George Pascal
Manoury Phillip
Obitz Daniel
Peynot Michel
Sevrin Mireille
Bernhardt Emily
Synthelabo
LandOfFree
1-[2-(1H-inden-3-yl)ethyl]-4-(naphth-1-yl)piperazine derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 1-[2-(1H-inden-3-yl)ethyl]-4-(naphth-1-yl)piperazine derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 1-[2-(1H-inden-3-yl)ethyl]-4-(naphth-1-yl)piperazine derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2188995